Data from AstraZeneca’s phase three trial results have recently become exposed, showing that within two years of receiving the shots, 1 in 3 participants reported suffering an adverse effect, and 1 in 35 experienced a “serious adverse event.”
The Canadian Independent also reported the disturbing data, quietly released late November 2023.
21,587 trial participants received the actual AstraZeneca shots compared to 10,793 who received a placebo. The data follows participants for two years after they received their COVID vaccine in 2021.
Of the 21,587 who received the shots, 621 individuals reported a serious adverse event (SAE), which is over 3%.
According to the data, “An SAE is an [Adverse Event] occurring during any study phase that fulfils 1 or more of the following criteria: death; immediately life-threatening; in-participant hospitalization or prolongation of existing hospitalization; persistent or significant disability or incapacity; congenital abnormality or birth defect; an important medical event.”
Moreover, a staggering 4,750 participants out of the 21,587 reportedly required medical attention (MAAE) after receiving the vaccine, which is over 1 out of every 5 people who took the experimental product.
Finally, adverse events of special interest (AESI) were reported by 2,516 participants, which is about 1 in 9 people, and is classified as “events of scientific and medical interest specific to the further understanding of the study intervention safety profile and required close monitoring and rapid communication by the investigators to the sponsor.”
Comparatively, the placebo group had much smaller numbers in all three categories. Only 1.3% reported an SAE (compared to 3.2%), 11.6% reported a MAAE (compared to 22%), and 5.5% reported an AESI (compared to 11.6%).
In all, of those who received the shots, more than 1 in 3 of AstraZeneca’s phase III trial participants reported an adverse event, compared to just less than 1 in 5 among the control group.
AstraZeneca pulls vaccines
AstraZeneca recently pulled its COVID shots off the European market, just one month after admitting in court for the first time that the jabs can cause rare but devastating side effects.
Now, it appears these side effects weren’t so rare after all, and they know it.
